Digital vs. Speculum Exams for PPROM (MOCA)

December 8, 2023 updated by: Washington University School of Medicine

Digital Versus Speculum Exams in Preterm Prelabor Rupture of Membranes: A Randomized Controlled Trial

After preterm prelabor rupture of membranes (PPROM)[breaking of the amniotic sac prior to 37 weeks gestation in pregnancy], patients are recommended for inpatient admission and close monitoring for complications including preterm labor, intraamniotic infection (infection of the sac around the baby), and placental abruption (separation of the placenta from wall of the uterus). When evaluation of cervical dilation is clinically indicated, obstetricians traditionally perform sterile speculum exams due to concern for decrease in pregnancy latency (length of time between breaking the water and delivery) with sterile digital exams in retrospective studies. These studies are concerning, however, by the indications for the exams and are at risk for confounding by indication. This is a randomized, non-inferiority trial to examine if sterile digital versus speculum exams effect latency of pregnancy in patients with PPROM.

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

86

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Missouri
      • Saint Louis, Missouri, United States, 63108
        • Recruiting
        • Barnes Jewish Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 22 weeks 0 days gestation to 33 weeks 5 days gestation
  • Clinical or laboratory confirmation of PPROM
  • At least 8 hours after rupture event
  • English speaking

Notably, for patients <25 weeks, approach for enrollment will be deferred until after the patient has discussed their desires for fetal resuscitation with the care team and are at a gestational age where they would desire this resuscitation.

Exclusion Criteria:

  • Contraindications to digital examination
  • COVID-19 positive on admission

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Speculum Exams
If a patient requires cervical evaluation after PPROM, their cervix will be evaluated with a sterile speculum exam. A sterile speculum with lubricating jelly will be inserted into the patient's vagina to visualize the cervix and visually estimate cervical dilation and effacement.
Same as arm
Active Comparator: Digital Exams
If a patient requires cervical evaluation after PPROM, their cervix will be evaluated with a digital exam. The provider will wear sterile gloves with lubricating jelly and will palpate the cervix to assess cervical dilation, effacement, and station.
Same as arm

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pregnancy latency
Time Frame: up to 10 weeks
time from admission to delivery
up to 10 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maternal chorioamnionitis
Time Frame: Prior to delivery
Per criteria of American College of Obstetricians and Gynecologists (ACOG): includes fever greater than or equal to 100.4 degrees Farenheit plus an additional sign such as fundal tenderness, white blood cell count >15, purulent vaginal discharge, fetal tachycardia, or placental culture with finding of chorioamnionitis. Suspected chorioamnionitis can also be diagnosed with isolated fever >102.2 degrees Fahrenheit
Prior to delivery
Endomyometritis
Time Frame: Within 2 weeks of delivery
Clinical diagnosis of uterine infection after delivery, typically with fever and fundal tenderness
Within 2 weeks of delivery
Maternal sepsis
Time Frame: Within 2 weeks of delivery
Defined as bacteremia with evidence of organ dysfunction
Within 2 weeks of delivery
Maternal wound infections
Time Frame: Within 2 weeks of delivery
As diagnosed by the clinicians
Within 2 weeks of delivery
Maternal intensive care unit (ICU) admission
Time Frame: Within 2 weeks of delivery
transfer to ICU or readmission to ICU
Within 2 weeks of delivery
Maternal death
Time Frame: Within 2 weeks postpartum
Death of mother
Within 2 weeks postpartum
Composite neonatal morbidity
Time Frame: 28 days of life
Need for respiratory support, neonatal sepsis, intraventricular hemorrhage, hypoxic ischemic encephalopathy, necrotizing enterocolitis, pneumonia, or neonatal demise
28 days of life
Length of neonatal intensive care unit (NICU) admission
Time Frame: Up to 1 year
From delivery until discharge from the NICU
Up to 1 year
Need for respiratory support
Time Frame: 28 days of life
One or more of the following: Continuous positive airway pressure (CPAP) or high-flow nasal cannula for at least 2 consecutive hours, supplemental oxygen with a fraction of inspired oxygen of at least 0.30 for at least 4 continuous hours, extracorporeal membrane oxygenation (ECMO), or mechanical ventilation
28 days of life
Neonatal sepsis at <72 hours of life
Time Frame: Within 72 hours of birth
must be confirmed on blood culture
Within 72 hours of birth
Neonatal sepsis at >72 hours of life
Time Frame: 28 days of life
must be confirmed on blood culture
28 days of life
Neonatal intraventricular hemorrhage (IVH)
Time Frame: 28 days of life
Seen on head ultrasound
28 days of life
Necrotizing enterocolitis (NEC)
Time Frame: 28 days of life
As diagnosed by NICU team
28 days of life
Hypoxic ischemic encephalopathy
Time Frame: 28 days of life
As diagnosed by NICU team
28 days of life
Neonatal pneumonia
Time Frame: 28 days of life
As diagnosed by NICU team
28 days of life
Neonatal death
Time Frame: During NICU admission, up to 1 year
As documented in the EMR
During NICU admission, up to 1 year
Patient satisfaction with exams
Time Frame: At delivery
Survey regarding their experience with cervical exams
At delivery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 27, 2023

Primary Completion (Estimated)

July 1, 2024

Study Completion (Estimated)

January 1, 2025

Study Registration Dates

First Submitted

February 21, 2023

First Submitted That Met QC Criteria

March 14, 2023

First Posted (Actual)

March 17, 2023

Study Record Updates

Last Update Posted (Estimated)

December 12, 2023

Last Update Submitted That Met QC Criteria

December 8, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on PPROM

Clinical Trials on Speculum Exams

3
Subscribe